DUALITYBIO-B (09606) announced that on December 13, 2025, its board of directors resolved to propose the adoption of the 2025 Share Scheme, subject to approval by shareholders. The 2025 Share Scheme aims to attract and retain participants who contribute significantly to the long-term development and success of the group, recognize their past contributions, provide them with opportunities to acquire proprietary interests in the company, and encourage further contributions to enhance the company's value for the benefit of all shareholders. The scheme offers flexible means to retain, incentivize, reward, compensate, and provide benefits to participants.